These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 2837968)

  • 1. Receptor-specific mechanisms for the responses of human leukocytes to leukotrienes.
    Goetzl EJ; Sherman JW; Ratnoff WD; Harvey JP; Eriksson E; Seaman WE; Baud L; Koo CH
    Ann N Y Acad Sci; 1988; 524():345-55. PubMed ID: 2837968
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of leukotrienes B4 and C4 on bovine aortic endothelial cell proliferation in vitro.
    Modat G; Muller A; Mary A; Grégoire C; Bonne C
    Prostaglandins; 1987 Apr; 33(4):531-8. PubMed ID: 3037607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of regulation of receptors and signal transduction pathways for the peptidyl leukotrienes.
    Crooke ST; Mong S; Sarau HM; Winkler JD; Vegesna VK
    Ann N Y Acad Sci; 1988; 524():153-61. PubMed ID: 2837951
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of arachidonic acid metabolites in local and systemic inflammatory processes.
    Austen KF
    Drugs; 1987; 33 Suppl 1():10-7. PubMed ID: 3036459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evidence for the chemotactic activity of cyclooxygenase- and lipoxygenase-dependent compounds using a corneal implantation technique.
    Rochels R; Busse WD
    Ophthalmic Res; 1984; 16(4):194-7. PubMed ID: 6089067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotrienes.
    Hammarström S
    Annu Rev Biochem; 1983; 52():355-77. PubMed ID: 6311078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and hypersensitivity.
    Goetzl EJ
    Int Ophthalmol Clin; 1985; 25(2):25-34. PubMed ID: 2989203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of leukotriene B4-specific chemotactic deactivation of human polymorphonuclear leukocytes.
    Boggs JM; Goetzl EJ
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():399-402. PubMed ID: 1847775
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacology of the leukotrienes].
    Sirois P; Borgeat P
    J Pharmacol; 1984; 15 Suppl 1():53-68. PubMed ID: 6328128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the generation and release of leukotrienes from leukocytes.
    Lewis RA
    Prog Clin Biol Res; 1985; 199():163-72. PubMed ID: 2999819
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular diversity of human leukocyte receptors.
    Koo CH; Sherman JW; Baud L; Goetzl E
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():191-4. PubMed ID: 2546383
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological actions of leukotrienes. State of the art lecture.
    Ford-Hutchinson A; Letts G
    Hypertension; 1986 Jun; 8(6 Pt 2):II44-9. PubMed ID: 3013771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes.
    Di Gennaro A; Carnini C; Buccellati C; Ballerio R; Zarini S; Fumagalli F; Viappiani S; Librizzi L; Hernandez A; Murphy RC; Constantin G; De Curtis M; Folco G; Sala A
    FASEB J; 2004 May; 18(7):842-4. PubMed ID: 15001558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonic acid metabolism by the 5-lipoxygenase pathway, and the effects of alternative dietary fatty acids.
    Lee TH; Austen KF
    Adv Immunol; 1986; 39():145-75. PubMed ID: 3098061
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products.
    Nagy L; Lee TH; Goetzl EJ; Pickett WC; Kay AB
    Clin Exp Immunol; 1982 Mar; 47(3):541-7. PubMed ID: 6282507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of 5-lipoxygenase metabolism by human neutrophils using a combination of activators.
    Maclouf J; Iliou JP; Del Maschio A
    Prostaglandins Leukot Med; 1986 Aug; 23(2-3):105-8. PubMed ID: 3020579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function.
    Lee TH; Hoover RL; Williams JD; Sperling RI; Ravalese J; Spur BW; Robinson DR; Corey EJ; Lewis RA; Austen KF
    N Engl J Med; 1985 May; 312(19):1217-24. PubMed ID: 2985986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between prostaglandins and leukotrienes.
    Kuehl FA; Dougherty HW; Ham EA
    Biochem Pharmacol; 1984 Jan; 33(1):1-5. PubMed ID: 6322789
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukotriene B4 is an incomplete agonist for the activation of human neutrophils.
    Prescott SM; Zimmerman GA; Seeger AR
    Biochem Biophys Res Commun; 1984 Jul; 122(2):535-41. PubMed ID: 6087805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of complement anaphylatoxins in neutrophil arachidonic acid metabolism.
    Clancy RM; Hugli TE
    Prog Clin Biol Res; 1985; 199():173-84. PubMed ID: 2999821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.